College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
J Am Board Fam Med. 2012 Nov-Dec;25(6):878-93. doi: 10.3122/jabfm.2012.06.120033.
Much of primary care involves helping patients manage symptoms. Nighttime sweating is a symptom linked to menopause, malignancies, autoimmune diseases, and infections. However, in primary care settings, night sweats are commonly reported by persons without these conditions.
We conducted a literature review, focusing on questions about definition, mechanisms, incidence/prevalence, measurement, clinical causes, evaluation, treatment, and prognosis. We limited our search to English language studies of adult humans published since 1966. Because studies of estrogen and androgen deficiency states had been reviewed by others, we excluded them. Search criteria were developed for each question. Publications meeting criteria were reviewed by the first 2 authors and consensus was reached through discussion.
Prevalence estimates ranged from 10% among older primary care patients to 60% among women on an obstetrics inpatient unit. Life expectancy of primary care patients reporting night sweats did not appear to be reduced. Although many clinical causes have been suggested, most are not well supported. Algorithmic approaches to evaluation are not evidence-based. Alpha adrenergic blockers may reduce night sweats in patients taking serotonin reuptake inhibitors. Thalidomide and thioridazine may benefit some terminal cancer patients with night sweats.
The symptom, night sweats, appears to be nonspecific. Many questions about causation, evaluation, and management remain unanswered.
大部分初级保健都涉及帮助患者控制症状。夜间出汗是与更年期、恶性肿瘤、自身免疫性疾病和感染相关的一种症状。然而,在初级保健环境中,没有这些疾病的人也经常会报告夜间出汗。
我们进行了文献回顾,重点关注有关定义、机制、发病率/患病率、测量、临床原因、评估、治疗和预后的问题。我们将搜索范围限制在 1966 年以后发表的以成年人为研究对象的英语语言研究。由于其他研究已经综述了雌激素和雄激素缺乏状态,因此我们将其排除在外。为每个问题制定了搜索标准。满足标准的出版物由前两位作者进行审查,并通过讨论达成共识。
患病率估计值从老年初级保健患者中的 10%到产科住院患者中的 60%不等。报告夜间出汗的初级保健患者的预期寿命似乎没有缩短。尽管已经提出了许多临床原因,但大多数都没有得到很好的支持。评估的算法方法没有循证医学证据支持。α肾上腺素能阻滞剂可能会减少正在服用 5-羟色胺再摄取抑制剂的患者的夜间出汗。沙利度胺和硫利达嗪可能对患有夜间出汗的晚期癌症患者有益。
症状,夜间出汗,似乎是非特异性的。关于病因、评估和管理的许多问题仍未得到解答。